Table 1 Distribution of the studied cases according to clinical outcomes, sex, and age
From: Prognostic significance of COVID-19 MSCT chest findings on short-term disease progression
No. = 300 | ||
|---|---|---|
Clinical outcomes | Group A | 75 (25.0%) |
Group B | 125 (41.7%) | |
Group C | 85 (28.3%) | |
Group D | 15 (5.0%) | |
Sex | Female | 152 (50.7%) |
Male | 148 (49.3%) | |
Age | Mean ± SD | 54.24 ± 13.51 |
Range | 20–90 | |